Home | Purity | Glutathione | AcetylCysteine

Medical Uses | Alcohol | References | Legal | Sitemap | Contact Us

[1]  Alsalim W, Fadel M (July 2003). "Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Oral methionine compared with intravenous n-acetyl cysteine for paracetamol overdose". Emergency medicine journal : EMJ 20 (4): 366–7. doi:10.1136/emj.20.4.366. PMID 12835357. PMC 1726135.

[2] Kasielski M, Nowak D: Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001, 95:448-456.

[3]Grand jean EM, Berthet P, Ruffmann R, Leuenberger P: Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo controlled clinical trials. Clin Ther 2000, 22:209-221.

[4]Stey C, Steurer J, Bachmann S, Medici TC, Tramer MR: The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review [In Process Citation]. Eur Respir J 2000, 16:253-262.

[5]Poole PJ, Black PN: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001, 322:1271-1274.

[6]Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (July 2000). "Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine". N. Engl. J. Med. 343 (3): 180–4. PMID 10900277. http://content.nejm.org/cgi/content/full/343/3/180.

[7]Marenzi G, Assanelli E, Marana I, et al. (June 2006). "N-acetylcysteine and contrast-induced nephropathy in primary angioplasty". N. Engl. J. Med. 354 (26): 2773–82. doi:10.1056/NEJMoa054209. PMID 16807414. http://content.nejm.org/cgi/content/full/354/26/2773.  

[8] Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF (2003). "Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial". JAMA the Journal of the American Medical Association 289: 553. doi:10.1001/jama.289.5.553. PMID 12578487. http://jama.ama-assn.org/cgi/content/full/289/5/553.

[9] Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI (September 2008). "N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial". Biol. Psychiatry 64 (5): 361–8. doi:10.1016/j.biopsych.2008.03.004. PMID 18436195.

[10] Berk M, Copolov DL, Dean O, et al. (September 2008). "N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial". Biol. Psychiatry 64 (6): 468–75. doi:10.1016/j.biopsych.2008.04.022. PMID 18534556.

[11] New Scientist 1999; Issue 2214, November 27

[12] Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ (1993). "Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard". Cell Biol. Toxicol. 9 (3): 259–67. doi:10.1007/BF00755604. PMID 8299004

[13] Chen, Y; Yang, Y; Miller, ML; Shen, D; Shertzer, HG; Stringer, KF; Wang, B; Schneider, SN et al. (2007). "Hepatocyte-specificGclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure". Hepatology 45 (5): 1118. doi:10.1002/hep.21635. PMID 17464988.

[14] Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF (October 2003). "The changing faces of glutathione, a cellular protagonist". Biochem Pharmacol. 66 (8): 1499–503. doi:10.1016/S0006-2952(03)00504-5. PMID 14555227. http://linkinghub.elsevier.com/retrieve/pii/S0006295203 005045.

[15] Wikipedia; Glutathione [LINK]

N-AcetylCysteine Information and References